Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethox y) - pyrimidin2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazi n-3-yl) -benzonitrile hydrochloride salt and processes of manufacturing thereof

Details for Australian Patent Application No. 2009336839 (hide)

International Classifications

Event Publications

25 August 2011 PCT application entered the National Phase

PCT publication WO2010/078897 Priority application(s): WO2010/078897

8 September 2011 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name MERCK PATENT GMBH, Application No. 2009336839, under INID (54) correct the title to read Novel polymorphic forms of 3-(1-{3-[5-(1-methyl-piperidin-4ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.